Barclays PLC Boston Scientific Corp Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Barclays PLC holds 4,046,518 shares of BSX stock, worth $306 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,046,518

Previous 3,374,723 19.91%

Holding current value

$306 Million

Previous $195 Million 42.06%

% of portfolio

0.1%

Previous 0.07%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$57.6 - $68.62 $38.7 Million - $46.1 Million	671,795 Added 19.91%	4,046,518 $277 Million
Q4 2023 Feb 15, 2024	SELL	$48.64 - $57.81 $38.8 Million - $46.2 Million	-798,464 Reduced 19.13%	3,374,723 $195 Million
Q3 2023 Nov 07, 2023	BUY	$50.19 - $54.68 $20.8 Million - $22.6 Million	413,994 Added 11.01%	4,173,187 $220 Million
Q2 2023 Aug 03, 2023	BUY	$49.72 - $54.64 $122 Million - $135 Million	2,461,951 Added 189.78%	3,759,193 $203 Million
Q1 2023 May 04, 2023	SELL	$45.09 - $50.03 $40.7 Million - $45.1 Million	-901,779 Reduced 41.01%	1,297,242 $64.9 Million

Q4 2022 Feb 13, 2023	BUY	$39.56 - $47.22 $22.7 Million - $27.1 Million	573,278 Added 35.26%	2,199,021 $102 Million
Q3 2022 Nov 03, 2022	BUY	$36.71 - $109.66 $8.33 Million - $24.9 Million	227,034 Added 16.23%	1,625,743 $63 Million
Q2 2022 Aug 12, 2022	SELL	$35.24 - $47.1 $22.8 Million - $30.4 Million	-645,611 Reduced 31.58%	1,398,709 $52.1 Million
Q1 2022 May 16, 2022	SELL	$40.9 - $45.1 $24.8 Million - $27.4 Million	-607,129 Reduced 22.9%	2,044,320 $90.5 Million
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $6.46 Million - $7.61 Million	-169,696 Reduced 6.02%	2,651,449 $113 Million
Q3 2021 Nov 09, 2021	BUY	$41.23 - $45.88 $29 Million - $32.3 Million	703,594 Added 33.23%	2,821,145 $122 Million
Q2 2021 Aug 13, 2021	BUY	$38.58 - $44.24 $20.2 Million - $23.2 Million	523,967 Added 32.88%	2,117,551 $90.5 Million
Q1 2021 May 13, 2021	BUY	$35.27 - $39.67 $425,673 - $478,777	12,069 Added 0.76%	1,593,584 $61.6 Million
Q4 2020 Feb 11, 2021	SELL	$33.15 - $41.97 $1.77 Million - $2.24 Million	-53,384 Reduced 3.27%	1,581,515 $56.9 Million
Q3 2020 Nov 12, 2020	BUY	$34.44 - $42.23 $21.9 Million - $26.8 Million	634,665 Added 63.45%	1,634,899 $62.5 Million
Q2 2020 Aug 12, 2020	SELL	$30.19 - $39.11 $58.6 Million - $75.9 Million	-1,940,660 Reduced 65.99%	1,000,234 $35.1 Million
Q1 2020 May 13, 2020	BUY	$25.83 - $45.71 $19 Million - $33.5 Million	733,795 Added 33.25%	2,940,894 $96 Million
Q4 2019 Feb 10, 2020	BUY	$37.87 - $45.37 $10.4 Million - $12.5 Million	275,882 Added 14.29%	2,207,099 $99.8 Million
Q3 2019 Nov 14, 2019	SELL	$40.31 - $43.45 $3.64 Million - $3.92 Million	-90,243 Reduced 4.46%	1,931,217 $78.6 Million
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $17.1 Million - $21 Million	489,526 Added 31.95%	2,021,460 $86.9 Million
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $5.72 Million - $7.09 Million	173,943 Added 12.81%	1,531,934 $58.8 Million
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $7.89 Million - $9.71 Million	-248,633 Reduced 15.48%	1,357,991 $48 Million
Q3 2018 Nov 14, 2018	SELL	$32.83 - $38.63 $14.3 Million - $16.8 Million	-435,464 Reduced 21.32%	1,606,624 $61.9 Million
Q2 2018 Aug 14, 2018	SELL	$26.84 - $34.32 $3.27 Million - $4.19 Million	-121,996 Reduced 5.64%	2,042,088 $66.8 Million
Q1 2018 May 15, 2018	SELL	$25.2 - $28.54 $3.52 Million - $3.98 Million	-139,527 Reduced 6.06%	2,164,084 $59.1 Million
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $35.4 Million - $42.6 Million	1,429,713 Added 163.6%	2,303,611 $57.1 Million
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $22.9 Million - $25.5 Million	873,898	873,898 $25.5 Million

Others Institutions Holding BSX

# of Institutions

1,319

Shares Held

1.17B

Call Options Held

5.92M

Put Options Held

5.75M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $108B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account